25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Nureca Ltd
Buy, Hold or Sell?

Let's analyze Nureca together

I guess you are interested in Nureca Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nureca Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Nureca Ltd

I send you an email if I find something interesting about Nureca Ltd.

1. Quick Overview

1.1. Quick analysis of Nureca (30 sec.)










1.2. What can you expect buying and holding a share of Nureca? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
INR193.11
Expected worth in 1 year
INR186.02
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
INR-7.09
Return On Investment
-2.5%

For what price can you sell your share?

Current Price per Share
INR282.25
Expected price per share
INR260.10 - INR323.05
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Nureca (5 min.)




Live pricePrice per Share (EOD)
INR282.25
Intrinsic Value Per Share
INR-463.90 - INR-562.95
Total Value Per Share
INR-270.80 - INR-369.84

2.2. Growth of Nureca (5 min.)




Is Nureca growing?

Current yearPrevious yearGrowGrow %
How rich?$22.7m$22.9m-$209k-0.9%

How much money is Nureca making?

Current yearPrevious yearGrowGrow %
Making money-$211.6k-$973.5k$761.8k359.9%
Net Profit Margin-2.0%-7.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Nureca (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Nureca?

Welcome investor! Nureca's management wants to use your money to grow the business. In return you get a share of Nureca.

First you should know what it really means to hold a share of Nureca. And how you can make/lose money.

Speculation

The Price per Share of Nureca is INR282.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nureca.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nureca, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR193.11. Based on the TTM, the Book Value Change Per Share is INR-1.77 per quarter. Based on the YOY, the Book Value Change Per Share is INR-8.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nureca.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.020.0%-0.020.0%-0.100.0%0.210.1%0.210.1%
Usd Book Value Change Per Share-0.020.0%-0.020.0%-0.100.0%0.460.2%0.460.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.040.0%0.040.0%
Usd Total Gains Per Share-0.020.0%-0.020.0%-0.100.0%0.490.2%0.490.2%
Usd Price Per Share3.01-3.01-3.54-5.95-5.95-
Price to Earnings Ratio-142.23--142.23--36.41--27.07--27.07-
Price-to-Total Gains Ratio-143.99--143.99--36.12--36.49--36.49-
Price to Book Ratio1.32-1.32-1.54-2.65-2.65-
Price-to-Total Gains Ratio-143.99--143.99--36.12--36.49--36.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.33055
Number of shares300
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.020.46
Usd Total Gains Per Share-0.020.49
Gains per Quarter (300 shares)-6.27147.32
Gains per Year (300 shares)-25.09589.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-25-3542547579
20-50-608510941168
30-75-8512716411757
40-100-11017021882346
50-125-13521227342935
60-151-16025532813524
70-176-18529738284113
80-201-21033943754702
90-226-23538249225291
100-251-26042454695880

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%3.00.02.060.0%3.00.02.060.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%3.02.00.060.0%3.02.00.060.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Nureca Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.772-1.7720%-8.315+369%38.621-105%38.621-105%
Book Value Per Share--193.106193.1060%194.878-1%153.841+26%153.841+26%
Current Ratio--20.76920.7690%21.002-1%14.333+45%14.333+45%
Debt To Asset Ratio--0.0590.0590%0.057+4%0.174-66%0.174-66%
Debt To Equity Ratio--0.0620.0620%0.060+4%0.322-81%0.322-81%
Dividend Per Share----0%-0%2.996-100%2.996-100%
Enterprise Value--2431001030.0002431001030.0000%2886580070.000-16%6144153497.500-60%6144153497.500-60%
Eps---1.794-1.7940%-8.250+360%17.537-110%17.537-110%
Ev To Ebitda Ratio--infinfnan%-36.520nan%infnan%infnan%
Ev To Sales Ratio--2.6442.6440%2.593+2%3.305-20%3.305-20%
Free Cash Flow Per Share---3.798-3.7980%9.831-139%5.447-170%5.447-170%
Free Cash Flow To Equity Per Share---3.798-3.7980%9.831-139%24.110-116%24.110-116%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---562.948--------
Intrinsic Value_10Y_min---463.902--------
Intrinsic Value_1Y_max---11.814--------
Intrinsic Value_1Y_min---11.479--------
Intrinsic Value_3Y_max---69.484--------
Intrinsic Value_3Y_min---65.015--------
Intrinsic Value_5Y_max---168.131--------
Intrinsic Value_5Y_min---151.595--------
Market Cap2822556450.000+10%2551551030.0002551551030.0000%3003560070.000-15%5040000798.000-49%5040000798.000-49%
Net Profit Margin---0.020-0.0200%-0.074+280%0.073-127%0.073-127%
Operating Margin----0%-0.1560%0.087-100%0.087-100%
Operating Ratio--1.7911.7910%1.835-2%1.532+17%1.532+17%
Pb Ratio1.462+10%1.3211.3210%1.541-14%2.652-50%2.652-50%
Pe Ratio-157.333-11%-142.227-142.2270%-36.407-74%-27.070-81%-27.070-81%
Price Per Share282.250+10%255.150255.1500%300.350-15%503.990-49%503.990-49%
Price To Free Cash Flow Ratio-74.317-11%-67.181-67.1810%30.552-320%-63.032-6%-63.032-6%
Price To Total Gains Ratio-159.286-11%-143.993-143.9930%-36.122-75%-36.492-75%-36.492-75%
Quick Ratio--10.94710.9470%15.529-30%8.277+32%8.277+32%
Return On Assets---0.009-0.0090%-0.040+357%0.119-107%0.119-107%
Return On Equity---0.009-0.0090%-0.042+356%0.176-105%0.176-105%
Total Gains Per Share---1.772-1.7720%-8.315+369%41.617-104%41.617-104%
Usd Book Value--22786980.00022786980.0000%22996076.000-1%18153639.200+26%18153639.200+26%
Usd Book Value Change Per Share---0.021-0.0210%-0.098+369%0.456-105%0.456-105%
Usd Book Value Per Share--2.2792.2790%2.300-1%1.815+26%1.815+26%
Usd Dividend Per Share----0%-0%0.035-100%0.035-100%
Usd Enterprise Value--28685812.15428685812.1540%34061644.826-16%72501011.271-60%72501011.271-60%
Usd Eps---0.021-0.0210%-0.097+360%0.207-110%0.207-110%
Usd Free Cash Flow---448164.000-448164.0000%1160058.000-139%642816.800-170%642816.800-170%
Usd Free Cash Flow Per Share---0.045-0.0450%0.116-139%0.064-170%0.064-170%
Usd Free Cash Flow To Equity Per Share---0.045-0.0450%0.116-139%0.284-116%0.284-116%
Usd Market Cap33306166.110+10%30108302.15430108302.1540%35442008.826-15%59472009.416-49%59472009.416-49%
Usd Price Per Share3.331+10%3.0113.0110%3.544-15%5.947-49%5.947-49%
Usd Profit---211692.000-211692.0000%-973500.000+360%2069366.000-110%2069366.000-110%
Usd Revenue--10847504.00010847504.0000%13136114.000-17%18211624.400-40%18211624.400-40%
Usd Total Gains Per Share---0.021-0.0210%-0.098+369%0.491-104%0.491-104%
 EOD+5 -3MRQTTM+0 -0YOY+16 -195Y+11 -2710Y+11 -27

3.3 Fundamental Score

Let's check the fundamental score of Nureca Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-157.333
Price to Book Ratio (EOD)Between0-11.462
Net Profit Margin (MRQ)Greater than0-0.020
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than110.947
Current Ratio (MRQ)Greater than120.769
Debt to Asset Ratio (MRQ)Less than10.059
Debt to Equity Ratio (MRQ)Less than10.062
Return on Equity (MRQ)Greater than0.15-0.009
Return on Assets (MRQ)Greater than0.05-0.009
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Nureca Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.674
Ma 20Greater thanMa 50281.650
Ma 50Greater thanMa 100292.893
Ma 100Greater thanMa 200299.466
OpenGreater thanClose287.800
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Nureca Ltd

Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, connected products, glucose meters, and thermometers; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, massagers, yoga and exercise products, fitness tracking products, and dental and personal care products. It also provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, blood pressure monitors, glucometer, fitness trackers, and smart weighing scales. The company offers its products under the Dr Trust, Dr Physio, and Trumom brands. It markets its products through e-commerce platforms, distributors, retailers, and its websites. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India.

Fundamental data was last updated by Penke on 2024-11-28 19:43:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Nureca earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Nureca to the Medical Devices industry mean.
  • A Net Profit Margin of -2.0% means that ₹-0.02 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nureca Ltd:

  • The MRQ is -2.0%. The company is making a loss. -1
  • The TTM is -2.0%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM-2.0%0.0%
TTM-2.0%YOY-7.4%+5.5%
TTM-2.0%5Y7.3%-9.2%
5Y7.3%10Y7.3%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.0%-6.4%+4.4%
TTM-2.0%-14.9%+12.9%
YOY-7.4%-15.4%+8.0%
5Y7.3%-17.9%+25.2%
10Y7.3%-21.7%+29.0%
4.3.1.2. Return on Assets

Shows how efficient Nureca is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nureca to the Medical Devices industry mean.
  • -0.9% Return on Assets means that Nureca generated ₹-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nureca Ltd:

  • The MRQ is -0.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-0.9%0.0%
TTM-0.9%YOY-4.0%+3.1%
TTM-0.9%5Y11.9%-12.8%
5Y11.9%10Y11.9%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%-2.1%+1.2%
TTM-0.9%-3.2%+2.3%
YOY-4.0%-4.0%+0.0%
5Y11.9%-3.0%+14.9%
10Y11.9%-4.0%+15.9%
4.3.1.3. Return on Equity

Shows how efficient Nureca is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nureca to the Medical Devices industry mean.
  • -0.9% Return on Equity means Nureca generated ₹-0.01 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nureca Ltd:

  • The MRQ is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-0.9%0.0%
TTM-0.9%YOY-4.2%+3.3%
TTM-0.9%5Y17.6%-18.6%
5Y17.6%10Y17.6%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%-2.4%+1.5%
TTM-0.9%-3.9%+3.0%
YOY-4.2%-4.5%+0.3%
5Y17.6%-4.0%+21.6%
10Y17.6%-5.5%+23.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Nureca Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Nureca is operating .

  • Measures how much profit Nureca makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nureca to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nureca Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-15.6%+15.6%
TTM-5Y8.7%-8.7%
5Y8.7%10Y8.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.1%+13.1%
TTM--20.2%+20.2%
YOY-15.6%-13.7%-1.9%
5Y8.7%-16.5%+25.2%
10Y8.7%-20.9%+29.6%
4.3.2.2. Operating Ratio

Measures how efficient Nureca is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.79 means that the operating costs are ₹1.79 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Nureca Ltd:

  • The MRQ is 1.791. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.791. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.791TTM1.7910.000
TTM1.791YOY1.835-0.044
TTM1.7915Y1.532+0.259
5Y1.53210Y1.5320.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7911.203+0.588
TTM1.7911.305+0.486
YOY1.8351.328+0.507
5Y1.5321.366+0.166
10Y1.5321.312+0.220
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Nureca Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Nureca is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 20.77 means the company has ₹20.77 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Nureca Ltd:

  • The MRQ is 20.769. The company is very able to pay all its short-term debts. +2
  • The TTM is 20.769. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ20.769TTM20.7690.000
TTM20.769YOY21.002-0.233
TTM20.7695Y14.333+6.436
5Y14.33310Y14.3330.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ20.7692.567+18.202
TTM20.7692.707+18.062
YOY21.0022.888+18.114
5Y14.3333.435+10.898
10Y14.3333.527+10.806
4.4.3.2. Quick Ratio

Measures if Nureca is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nureca to the Medical Devices industry mean.
  • A Quick Ratio of 10.95 means the company can pay off ₹10.95 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nureca Ltd:

  • The MRQ is 10.947. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.947. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.947TTM10.9470.000
TTM10.947YOY15.529-4.582
TTM10.9475Y8.277+2.670
5Y8.27710Y8.2770.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ10.9471.442+9.505
TTM10.9471.678+9.269
YOY15.5291.892+13.637
5Y8.2772.299+5.978
10Y8.2772.555+5.722
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Nureca Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Nureca assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nureca to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.06 means that Nureca assets are financed with 5.9% credit (debt) and the remaining percentage (100% - 5.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nureca Ltd:

  • The MRQ is 0.059. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.059. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.059TTM0.0590.000
TTM0.059YOY0.057+0.002
TTM0.0595Y0.174-0.115
5Y0.17410Y0.1740.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0590.401-0.342
TTM0.0590.401-0.342
YOY0.0570.362-0.305
5Y0.1740.431-0.257
10Y0.1740.453-0.279
4.5.4.2. Debt to Equity Ratio

Measures if Nureca is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nureca to the Medical Devices industry mean.
  • A Debt to Equity ratio of 6.2% means that company has ₹0.06 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nureca Ltd:

  • The MRQ is 0.062. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.062. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.0620.000
TTM0.062YOY0.060+0.002
TTM0.0625Y0.322-0.259
5Y0.32210Y0.3220.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0620.565-0.503
TTM0.0620.600-0.538
YOY0.0600.535-0.475
5Y0.3220.635-0.313
10Y0.3220.712-0.390
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Nureca generates.

  • Above 15 is considered overpriced but always compare Nureca to the Medical Devices industry mean.
  • A PE ratio of -142.23 means the investor is paying ₹-142.23 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nureca Ltd:

  • The EOD is -157.333. Based on the earnings, the company is expensive. -2
  • The MRQ is -142.227. Based on the earnings, the company is expensive. -2
  • The TTM is -142.227. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-157.333MRQ-142.227-15.106
MRQ-142.227TTM-142.2270.000
TTM-142.227YOY-36.407-105.820
TTM-142.2275Y-27.070-115.157
5Y-27.07010Y-27.0700.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-157.333-0.959-156.374
MRQ-142.227-1.344-140.883
TTM-142.227-1.807-140.420
YOY-36.407-2.324-34.083
5Y-27.070-2.138-24.932
10Y-27.070-1.952-25.118
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nureca Ltd:

  • The EOD is -74.317. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -67.181. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -67.181. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-74.317MRQ-67.181-7.135
MRQ-67.181TTM-67.1810.000
TTM-67.181YOY30.552-97.733
TTM-67.1815Y-63.032-4.149
5Y-63.03210Y-63.0320.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-74.317-1.459-72.858
MRQ-67.181-1.910-65.271
TTM-67.181-2.233-64.948
YOY30.552-5.444+35.996
5Y-63.032-4.008-59.024
10Y-63.032-4.828-58.204
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Nureca is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.32 means the investor is paying ₹1.32 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Nureca Ltd:

  • The EOD is 1.462. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.321. Based on the equity, the company is underpriced. +1
  • The TTM is 1.321. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.462MRQ1.321+0.140
MRQ1.321TTM1.3210.000
TTM1.321YOY1.541-0.220
TTM1.3215Y2.652-1.330
5Y2.65210Y2.6520.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.4622.149-0.687
MRQ1.3212.142-0.821
TTM1.3212.344-1.023
YOY1.5413.005-1.464
5Y2.6524.023-1.371
10Y2.6524.497-1.845
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets2,051,650
Total Liabilities120,550
Total Stockholder Equity1,931,100
 As reported
Total Liabilities 120,550
Total Stockholder Equity+ 1,931,100
Total Assets = 2,051,650

Assets

Total Assets2,051,650
Total Current Assets1,925,920
Long-term Assets125,730
Total Current Assets
Cash And Cash Equivalents 140,620
Short-term Investments 998,930
Net Receivables 16,150
Inventory 308,510
Other Current Assets 2,460
Total Current Assets  (as reported)1,925,920
Total Current Assets  (calculated)1,466,670
+/- 459,250
Long-term Assets
Property Plant Equipment 50,810
Intangible Assets 22,970
Long-term Assets Other 10
Long-term Assets  (as reported)125,730
Long-term Assets  (calculated)73,790
+/- 51,940

Liabilities & Shareholders' Equity

Total Current Liabilities92,730
Long-term Liabilities27,820
Total Stockholder Equity1,931,100
Total Current Liabilities
Short Long Term Debt 1,580
Accounts payable 51,740
Other Current Liabilities 8,800
Total Current Liabilities  (as reported)92,730
Total Current Liabilities  (calculated)62,120
+/- 30,610
Long-term Liabilities
Long term Debt 3,260
Capital Lease Obligations Min Short Term Debt20,320
Long-term Liabilities Other 10
Long-term Liabilities  (as reported)27,820
Long-term Liabilities  (calculated)23,590
+/- 4,230
Total Stockholder Equity
Retained Earnings 856,380
Total Stockholder Equity (as reported)1,931,100
Total Stockholder Equity (calculated)856,380
+/- 1,074,720
Other
Capital Stock100,000
Common Stock Shares Outstanding 10,000
Net Invested Capital 1,935,940
Net Working Capital 1,833,190
Property Plant and Equipment Gross 86,880



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-31
> Total Assets 
338,830
1,857,520
2,191,300
2,065,800
2,051,650
2,051,6502,065,8002,191,3001,857,520338,830
   > Total Current Assets 
327,520
1,811,200
2,061,930
1,865,630
1,925,920
1,925,9201,865,6302,061,9301,811,200327,520
       Cash And Cash Equivalents 
740
172,420
82,490
5,040
140,620
140,6205,04082,490172,420740
       Short-term Investments 
0
1,094,500
918,020
1,336,450
998,930
998,9301,336,450918,0201,094,5000
       Net Receivables 
128,970
2,240
28,940
42,950
16,150
16,15042,95028,9402,240128,970
       Inventory 
164,260
367,760
631,770
344,770
308,510
308,510344,770631,770367,760164,260
       Other Current Assets 
13,630
519,310
405,290
127,100
2,460
2,460127,100405,290519,31013,630
   > Long-term Assets 
11,310
46,320
129,370
200,170
125,730
125,730200,170129,37046,32011,310
       Property Plant Equipment 
10,640
36,830
77,970
60,410
50,810
50,81060,41077,97036,83010,640
       Intangible Assets 
0
3,020
28,150
26,130
22,970
22,97026,13028,1503,0200
       Other Assets 
670
6,470
3,750
38,380
0
038,3803,7506,470670
> Total Liabilities 
189,490
226,530
159,330
116,980
120,550
120,550116,980159,330226,530189,490
   > Total Current Liabilities 
95,030
188,670
122,380
88,830
92,730
92,73088,830122,380188,67095,030
       Short Long Term Debt 
750
2,190
760
820
1,580
1,5808207602,190750
       Accounts payable 
58,310
87,440
47,210
49,900
51,740
51,74049,90047,21087,44058,310
       Other Current Liabilities 
29,660
87,290
50,850
23,630
8,800
8,80023,63050,85087,29029,660
   > Long-term Liabilities 
94,460
37,860
36,950
28,150
27,820
27,82028,15036,95037,86094,460
       Long term Debt 
90,740
7,790
0
0
3,260
3,260007,79090,740
       Capital Lease Obligations Min Short Term Debt
6,300
28,870
43,290
32,450
20,320
20,32032,45043,29028,8706,300
       Other Liabilities 
1,010
4,510
4,130
0
0
004,1304,5101,010
       Long-term Liabilities Other 
-10
-10
10
0
10
10010-10-10
> Total Stockholder Equity
149,340
1,630,990
2,031,970
1,948,820
1,931,100
1,931,1001,948,8202,031,9701,630,990149,340
   Common Stock
100
100,000
100,000
0
0
00100,000100,000100
   Retained Earnings 
152,300
556,130
957,140
874,070
856,380
856,380874,070957,140556,130152,300
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 00-12,950-12,940-3,060



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue919,280
Cost of Revenue-606,150
Gross Profit313,130313,130
 
Operating Income (+$)
Gross Profit313,130
Operating Expense-1,040,320
Operating Income-121,040-727,190
 
Operating Expense (+$)
Research Development0
Selling General Administrative124,030
Selling And Marketing Expenses0
Operating Expense1,040,320124,030
 
Net Interest Income (+$)
Interest Income38,920
Interest Expense-3,180
Other Finance Cost-1,710
Net Interest Income34,030
 
Pretax Income (+$)
Operating Income-121,040
Net Interest Income34,030
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-25,440-121,040
EBIT - interestExpense = -3,180
-17,940
-14,760
Interest Expense3,180
Earnings Before Interest and Taxes (EBIT)0-22,260
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-25,440
Tax Provision--7,500
Net Income From Continuing Ops-17,940-17,940
Net Income-17,940
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-34,030
 

Technical Analysis of Nureca
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nureca. The general trend of Nureca is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nureca's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nureca Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 307.95 < 309.00 < 323.05.

The bearish price targets are: 264.00 > 260.75 > 260.10.

Tweet this
Nureca Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nureca Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nureca Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nureca Ltd. The current macd is -1.04983694.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nureca price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Nureca. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Nureca price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Nureca Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNureca Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nureca Ltd. The current adx is 17.31.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Nureca shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Nureca Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nureca Ltd. The current sar is 278.17.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Nureca Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nureca Ltd. The current rsi is 45.67. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Nureca Ltd Daily Relative Strength Index (RSI) ChartNureca Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nureca Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nureca price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Nureca Ltd Daily Stochastic Oscillator ChartNureca Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nureca Ltd. The current cci is 8.00970652.

Nureca Ltd Daily Commodity Channel Index (CCI) ChartNureca Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nureca Ltd. The current cmo is -10.89988865.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Nureca Ltd Daily Chande Momentum Oscillator (CMO) ChartNureca Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nureca Ltd. The current willr is -62.83618582.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Nureca is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Nureca Ltd Daily Williams %R ChartNureca Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nureca Ltd.

Nureca Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nureca Ltd. The current atr is 11.77.

Nureca Ltd Daily Average True Range (ATR) ChartNureca Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nureca Ltd. The current obv is 1,455,115.

Nureca Ltd Daily On-Balance Volume (OBV) ChartNureca Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nureca Ltd. The current mfi is 26.39.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Nureca Ltd Daily Money Flow Index (MFI) ChartNureca Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nureca Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Nureca Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nureca Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.674
Ma 20Greater thanMa 50281.650
Ma 50Greater thanMa 100292.893
Ma 100Greater thanMa 200299.466
OpenGreater thanClose287.800
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Nureca with someone you think should read this too:
  • Are you bullish or bearish on Nureca? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nureca? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nureca Ltd

I send you an email if I find something interesting about Nureca Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Nureca Ltd.

Receive notifications about Nureca Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.